Literature DB >> 17217938

Derepression of pathological cardiac genes by members of the CaM kinase superfamily.

Timothy A McKinsey1.   

Abstract

In response to pathologic stresses such as hypertension or myocardial infarction, the heart undergoes a remodeling process that is characterized by myocyte hypertrophy, myocyte death and fibrosis, resulting in impaired cardiac function and heart failure. Cardiac remodeling is associated with derepression of genes that contribute to disease progression. This review focuses on evidence linking members of the Ca(2+)/calmodulin-dependent protein kinase (CaMK) superfamily, specifically CaMKII, protein kinase D (PKD) and microtubule associated kinase (MARK), to stress-induced derepression of pathological cardiac gene expression through their effects on class IIa histone deacetylases (HDACs).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17217938     DOI: 10.1016/j.cardiores.2006.11.036

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  51 in total

Review 1.  Is CaMKII a link between inflammation and hypertrophy in heart?

Authors:  Madhu V Singh; Mark E Anderson
Journal:  J Mol Med (Berl)       Date:  2011-01-29       Impact factor: 4.599

Review 2.  Protein kinase D as a potential new target for cancer therapy.

Authors:  Courtney R LaValle; Kara M George; Elizabeth R Sharlow; John S Lazo; Peter Wipf; Q Jane Wang
Journal:  Biochim Biophys Acta       Date:  2010-05-24

Review 3.  Calcium/calmodulin-dependent protein kinase kinase 2: roles in signaling and pathophysiology.

Authors:  Luigi Racioppi; Anthony R Means
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

4.  HDAC5 catalytic activity suppresses cardiomyocyte oxidative stress and NRF2 target gene expression.

Authors:  Tianjing Hu; Friederike C Schreiter; Rushita A Bagchi; Philip D Tatman; Mark Hannink; Timothy A McKinsey
Journal:  J Biol Chem       Date:  2019-04-08       Impact factor: 5.157

5.  Dysfunctional ryanodine receptor and cardiac hypertrophy: role of signaling molecules.

Authors:  Naohiro Yamaguchi; Asima Chakraborty; Daniel A Pasek; Jeffery D Molkentin; Gerhard Meissner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-03-18       Impact factor: 4.733

Review 6.  Regulation of cardiac myocyte cell death and differentiation by myocardin.

Authors:  Joseph W Gordon
Journal:  Mol Cell Biochem       Date:  2017-06-19       Impact factor: 3.396

7.  AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway.

Authors:  Graeme K Carnegie; Joseph Soughayer; F Donelson Smith; Benjamin S Pedroja; Fang Zhang; Dario Diviani; Michael R Bristow; Maya T Kunkel; Alexandra C Newton; Lorene K Langeberg; John D Scott
Journal:  Mol Cell       Date:  2008-10-24       Impact factor: 17.970

8.  The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload.

Authors:  Johannes Backs; Thea Backs; Stefan Neef; Michael M Kreusser; Lorenz H Lehmann; David M Patrick; Chad E Grueter; Xiaoxia Qi; James A Richardson; Joseph A Hill; Hugo A Katus; Rhonda Bassel-Duby; Lars S Maier; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

9.  A Novel Conserved Domain Mediates Dimerization of Protein Kinase D (PKD) Isoforms: DIMERIZATION IS ESSENTIAL FOR PKD-DEPENDENT REGULATION OF SECRETION AND INNATE IMMUNITY.

Authors:  Clara Aicart-Ramos; Sophia Dan Qing He; Marianne Land; Charles S Rubin
Journal:  J Biol Chem       Date:  2016-09-23       Impact factor: 5.157

10.  Histone deacetylase 5 interacts with Krüppel-like factor 2 and inhibits its transcriptional activity in endothelium.

Authors:  Il-Sun Kwon; Weiye Wang; Suowen Xu; Zheng-Gen Jin
Journal:  Cardiovasc Res       Date:  2014-08-05       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.